SlideShare a Scribd company logo
1 of 8
THE CLININOVA RESEARCH LABS   1
1. CERTAIN
•   A clinical event, including laboratory test abnormality, occurring in a plausible
    time relationship to drug administration, and which cannot be explained by
    concurrent disease or other drugs or chemicals.




                                THE CLININOVA RESEARCH LABS                             2
2.PROBABLE/ LIKELY

• A clinical event, including laboratory test abnormality, with a reasonable
  time sequence to administration of the drug, unlikely to be attributed to
  concurrent disease or other drugs or chemicals




                             THE CLININOVA RESEARCH LABS                       3
3.POSSIBLE

• A clinical event, including laboratory test abnormality, with a reasonable
  time sequence to administration of the drug, but which could also be
  explained by concurrent disease or other drugs or chemicals




                             THE CLININOVA RESEARCH LABS                       4
4.UNLIKELY

• A clinical event, including laboratory test abnormality, with a temporal
  relationship to drug administration which makes a causal relationship
  improbable, and in which other drugs, chemicals or underlying disease
  provide plausible explanations.




                             THE CLININOVA RESEARCH LABS                     5
5.CONDITIONAL/ UNCLASSIFIED

•   A clinical event, including laboratory test abnormality, reported as an adverse
    reaction, about which more data is essential for a proper assessment




                                THE CLININOVA RESEARCH LABS                     6
6.UNASSESSIBLE/ UNCLASSIFIABLE
•   A report suggesting an adverse reaction which cannot be judged because
    information is insufficient or contradictory, and which cannot be
    supplemented or verified.




                                THE CLININOVA RESEARCH LABS                  7
THE CLININOVA RESEARCH LABS   8

More Related Content

Viewers also liked

SDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical EventsSDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical EventsVijayaraghava Karpurapu
 
Presentation on CDISC- SDTM guidelines.
Presentation on CDISC- SDTM guidelines.Presentation on CDISC- SDTM guidelines.
Presentation on CDISC- SDTM guidelines.Khushbu Shah
 
Importance of zero
Importance of zeroImportance of zero
Importance of zeromalinibindra
 
History of Zero - Mathematics
History of  Zero - MathematicsHistory of  Zero - Mathematics
History of Zero - Mathematicsdivya rajput
 
Time management ppt
Time management pptTime management ppt
Time management pptUzma Batool
 
TIME MANAGEMENT POWERPOINT
TIME MANAGEMENT POWERPOINTTIME MANAGEMENT POWERPOINT
TIME MANAGEMENT POWERPOINTAndrew Schwartz
 

Viewers also liked (10)

SDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical EventsSDTM - Adverse Events Vs. Clinical Events
SDTM - Adverse Events Vs. Clinical Events
 
Presentation on CDISC- SDTM guidelines.
Presentation on CDISC- SDTM guidelines.Presentation on CDISC- SDTM guidelines.
Presentation on CDISC- SDTM guidelines.
 
Divya chhabra
Divya chhabraDivya chhabra
Divya chhabra
 
Importance of zero
Importance of zeroImportance of zero
Importance of zero
 
History of Zero - Mathematics
History of  Zero - MathematicsHistory of  Zero - Mathematics
History of Zero - Mathematics
 
Purpose of life
Purpose of lifePurpose of life
Purpose of life
 
how to manage you time
how to manage you timehow to manage you time
how to manage you time
 
Time Management
Time ManagementTime Management
Time Management
 
Time management ppt
Time management pptTime management ppt
Time management ppt
 
TIME MANAGEMENT POWERPOINT
TIME MANAGEMENT POWERPOINTTIME MANAGEMENT POWERPOINT
TIME MANAGEMENT POWERPOINT
 

Similar to Clininova Labs Adverse Reaction Classifications

Who causality assessment scale
Who causality assessment scaleWho causality assessment scale
Who causality assessment scaleSHARIQUE RAZA
 
_CHEMICAL PATHOLOGY`Intro 2022.pptx
_CHEMICAL PATHOLOGY`Intro 2022.pptx_CHEMICAL PATHOLOGY`Intro 2022.pptx
_CHEMICAL PATHOLOGY`Intro 2022.pptxTiekuNoble1
 
Adverse event reporting
Adverse event reportingAdverse event reporting
Adverse event reportingBhushanSurana2
 
Unveiling the complexity: understanding errors in animal experiments
Unveiling the complexity: understanding errors in animal experimentsUnveiling the complexity: understanding errors in animal experiments
Unveiling the complexity: understanding errors in animal experimentsSACHINNAYAK74
 
Laboratory Diagnosis: Relevance to patient healthcare.pptx
Laboratory Diagnosis: Relevance to patient healthcare.pptxLaboratory Diagnosis: Relevance to patient healthcare.pptx
Laboratory Diagnosis: Relevance to patient healthcare.pptxTemitopeOlusanya3
 
MBBS intro CHEM path 1 ppt.ppt
MBBS intro CHEM path 1 ppt.pptMBBS intro CHEM path 1 ppt.ppt
MBBS intro CHEM path 1 ppt.pptByamugishaJames
 
Clinical Trials,Hypersenstivity,types of drug interactions.pptx
Clinical Trials,Hypersenstivity,types of drug interactions.pptxClinical Trials,Hypersenstivity,types of drug interactions.pptx
Clinical Trials,Hypersenstivity,types of drug interactions.pptxDrNailaRiasatAli
 
Ventilator associated pneumonia (1).pptx
Ventilator associated pneumonia (1).pptxVentilator associated pneumonia (1).pptx
Ventilator associated pneumonia (1).pptxrekha reddy
 
Nursing Case Urinary Tract Infection.docx
Nursing Case Urinary Tract Infection.docxNursing Case Urinary Tract Infection.docx
Nursing Case Urinary Tract Infection.docxbkbk37
 
8-Clinical Trial Studies
8-Clinical Trial Studies8-Clinical Trial Studies
8-Clinical Trial StudiesResearchGuru
 
Urinary tract infections
Urinary tract infectionsUrinary tract infections
Urinary tract infectionsSandro Zorzi
 
Causality assessment,methods,pharmacovigilance
Causality assessment,methods,pharmacovigilanceCausality assessment,methods,pharmacovigilance
Causality assessment,methods,pharmacovigilanceGaurav Chhabra
 
Sbsbbeb e71218134012 (1).pptx
Sbsbbeb e71218134012 (1).pptxSbsbbeb e71218134012 (1).pptx
Sbsbbeb e71218134012 (1).pptxMahaShyam
 
Acp guidelines for pharmacists ordering lab tests and using laboratory data ...
Acp guidelines for pharmacists  ordering lab tests and using laboratory data ...Acp guidelines for pharmacists  ordering lab tests and using laboratory data ...
Acp guidelines for pharmacists ordering lab tests and using laboratory data ...M. Luisetto Pharm.D.Spec. Pharmacology
 
074b0dc0-c56e-4e71-af85-30012e81e450.pdf
074b0dc0-c56e-4e71-af85-30012e81e450.pdf074b0dc0-c56e-4e71-af85-30012e81e450.pdf
074b0dc0-c56e-4e71-af85-30012e81e450.pdfAmar Prasad
 

Similar to Clininova Labs Adverse Reaction Classifications (20)

Who causality assessment scale
Who causality assessment scaleWho causality assessment scale
Who causality assessment scale
 
Causality Assessment
Causality AssessmentCausality Assessment
Causality Assessment
 
_CHEMICAL PATHOLOGY`Intro 2022.pptx
_CHEMICAL PATHOLOGY`Intro 2022.pptx_CHEMICAL PATHOLOGY`Intro 2022.pptx
_CHEMICAL PATHOLOGY`Intro 2022.pptx
 
RCT CH1.ppt
RCT CH1.pptRCT CH1.ppt
RCT CH1.ppt
 
Adverse event reporting
Adverse event reportingAdverse event reporting
Adverse event reporting
 
Unveiling the complexity: understanding errors in animal experiments
Unveiling the complexity: understanding errors in animal experimentsUnveiling the complexity: understanding errors in animal experiments
Unveiling the complexity: understanding errors in animal experiments
 
Laboratory Diagnosis: Relevance to patient healthcare.pptx
Laboratory Diagnosis: Relevance to patient healthcare.pptxLaboratory Diagnosis: Relevance to patient healthcare.pptx
Laboratory Diagnosis: Relevance to patient healthcare.pptx
 
MBBS intro CHEM path 1 ppt.ppt
MBBS intro CHEM path 1 ppt.pptMBBS intro CHEM path 1 ppt.ppt
MBBS intro CHEM path 1 ppt.ppt
 
Clinical Trials,Hypersenstivity,types of drug interactions.pptx
Clinical Trials,Hypersenstivity,types of drug interactions.pptxClinical Trials,Hypersenstivity,types of drug interactions.pptx
Clinical Trials,Hypersenstivity,types of drug interactions.pptx
 
Ventilator associated pneumonia (1).pptx
Ventilator associated pneumonia (1).pptxVentilator associated pneumonia (1).pptx
Ventilator associated pneumonia (1).pptx
 
Nursing Case Urinary Tract Infection.docx
Nursing Case Urinary Tract Infection.docxNursing Case Urinary Tract Infection.docx
Nursing Case Urinary Tract Infection.docx
 
BIOSTAT_GROUP-5-Section-7.pptx
BIOSTAT_GROUP-5-Section-7.pptxBIOSTAT_GROUP-5-Section-7.pptx
BIOSTAT_GROUP-5-Section-7.pptx
 
experimental study.pptx
experimental study.pptxexperimental study.pptx
experimental study.pptx
 
8-Clinical Trial Studies
8-Clinical Trial Studies8-Clinical Trial Studies
8-Clinical Trial Studies
 
Urinary tract infections
Urinary tract infectionsUrinary tract infections
Urinary tract infections
 
Causality assessment,methods,pharmacovigilance
Causality assessment,methods,pharmacovigilanceCausality assessment,methods,pharmacovigilance
Causality assessment,methods,pharmacovigilance
 
Sbsbbeb e71218134012 (1).pptx
Sbsbbeb e71218134012 (1).pptxSbsbbeb e71218134012 (1).pptx
Sbsbbeb e71218134012 (1).pptx
 
Placebo
Placebo Placebo
Placebo
 
Acp guidelines for pharmacists ordering lab tests and using laboratory data ...
Acp guidelines for pharmacists  ordering lab tests and using laboratory data ...Acp guidelines for pharmacists  ordering lab tests and using laboratory data ...
Acp guidelines for pharmacists ordering lab tests and using laboratory data ...
 
074b0dc0-c56e-4e71-af85-30012e81e450.pdf
074b0dc0-c56e-4e71-af85-30012e81e450.pdf074b0dc0-c56e-4e71-af85-30012e81e450.pdf
074b0dc0-c56e-4e71-af85-30012e81e450.pdf
 

More from rahulrabbit

Nanotechnology in artificial RBC
Nanotechnology in artificial RBCNanotechnology in artificial RBC
Nanotechnology in artificial RBCrahulrabbit
 
Study data tabulation model
Study data tabulation modelStudy data tabulation model
Study data tabulation modelrahulrabbit
 
Drug and cosmetic act
Drug and cosmetic actDrug and cosmetic act
Drug and cosmetic actrahulrabbit
 
Cdsco gcp different secctions
Cdsco gcp different secctionsCdsco gcp different secctions
Cdsco gcp different secctionsrahulrabbit
 

More from rahulrabbit (9)

Nanotechnology in artificial RBC
Nanotechnology in artificial RBCNanotechnology in artificial RBC
Nanotechnology in artificial RBC
 
Study data tabulation model
Study data tabulation modelStudy data tabulation model
Study data tabulation model
 
Cfsan 1
Cfsan 1Cfsan 1
Cfsan 1
 
Ralfinamide
RalfinamideRalfinamide
Ralfinamide
 
Ich gcp
Ich gcpIch gcp
Ich gcp
 
Sponsor
SponsorSponsor
Sponsor
 
Ich & indian
Ich & indianIch & indian
Ich & indian
 
Drug and cosmetic act
Drug and cosmetic actDrug and cosmetic act
Drug and cosmetic act
 
Cdsco gcp different secctions
Cdsco gcp different secctionsCdsco gcp different secctions
Cdsco gcp different secctions
 

Recently uploaded

A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 

Recently uploaded (20)

Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 

Clininova Labs Adverse Reaction Classifications

  • 2. 1. CERTAIN • A clinical event, including laboratory test abnormality, occurring in a plausible time relationship to drug administration, and which cannot be explained by concurrent disease or other drugs or chemicals. THE CLININOVA RESEARCH LABS 2
  • 3. 2.PROBABLE/ LIKELY • A clinical event, including laboratory test abnormality, with a reasonable time sequence to administration of the drug, unlikely to be attributed to concurrent disease or other drugs or chemicals THE CLININOVA RESEARCH LABS 3
  • 4. 3.POSSIBLE • A clinical event, including laboratory test abnormality, with a reasonable time sequence to administration of the drug, but which could also be explained by concurrent disease or other drugs or chemicals THE CLININOVA RESEARCH LABS 4
  • 5. 4.UNLIKELY • A clinical event, including laboratory test abnormality, with a temporal relationship to drug administration which makes a causal relationship improbable, and in which other drugs, chemicals or underlying disease provide plausible explanations. THE CLININOVA RESEARCH LABS 5
  • 6. 5.CONDITIONAL/ UNCLASSIFIED • A clinical event, including laboratory test abnormality, reported as an adverse reaction, about which more data is essential for a proper assessment THE CLININOVA RESEARCH LABS 6
  • 7. 6.UNASSESSIBLE/ UNCLASSIFIABLE • A report suggesting an adverse reaction which cannot be judged because information is insufficient or contradictory, and which cannot be supplemented or verified. THE CLININOVA RESEARCH LABS 7